190 related articles for article (PubMed ID: 2458118)
21. Myocardial oxygen supply under critical conditions, the effects of hemodilution and fluorocarbons.
Fennema M; Erdmann W; Faithfull NS
Adv Exp Med Biol; 1992; 317():527-44. PubMed ID: 1288170
[TBL] [Abstract][Full Text] [Related]
22. Importance of severity of coronary artery disease for the tolerance to normovolemic hemodilution. Comparison of single-vessel versus multivessel stenoses in a canine model.
Spahn DR; Smith LR; Schell RM; Hoffman RD; Gillespie R; Leone BJ
J Thorac Cardiovasc Surg; 1994 Aug; 108(2):231-9. PubMed ID: 8041171
[TBL] [Abstract][Full Text] [Related]
23. The effect of hemodilution with stroma-free hemoglobin and dextran on collateral perfusion of ischemic myocardium in the dog.
Biro GP; Beresford-Kroeger D
Am Heart J; 1980 Jan; 99(1):64-75. PubMed ID: 7350753
[TBL] [Abstract][Full Text] [Related]
24. Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis.
Most AS; Ruocco NA; Gewirtz H
Circulation; 1986 Nov; 74(5):1085-92. PubMed ID: 3769166
[TBL] [Abstract][Full Text] [Related]
25. Oxygen supply and microcirculation of the beating dog heart after haemodilution with fluosol DA 20%.
Harrison DK; Günther H; Vogel H; Ellermann R; Brunner M; Höper J; Kessler M
Adv Exp Med Biol; 1985; 191():445-52. PubMed ID: 3832859
[No Abstract] [Full Text] [Related]
26. Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow.
Spahn DR; Smith LR; Veronee CD; McRae RL; Hu WC; Menius AJ; Lowe JE; Leone BJ
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):694-704. PubMed ID: 8469004
[TBL] [Abstract][Full Text] [Related]
27. Fluosol-DA: an artificial blood for total cardiopulmonary bypass.
Engelman RM; Rousou JH; Dobbs WA
Ann Thorac Surg; 1981 Dec; 32(6):528-35. PubMed ID: 7316587
[TBL] [Abstract][Full Text] [Related]
28. [The place for using erythrocyte substitutes in hemodilution: fluosol-DA and polymerized pyridoxylated hemoglobin].
Vigneron C; Labrude P; Dellacherie E
Ann Fr Anesth Reanim; 1986; 5(3):260-8. PubMed ID: 3535579
[TBL] [Abstract][Full Text] [Related]
29. Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmia.
Kolodgie FD; Dawson AK; Roden DM; Forman MB; Virmani R
Am Heart J; 1986 Dec; 112(6):1192-201. PubMed ID: 3788766
[TBL] [Abstract][Full Text] [Related]
30. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
[TBL] [Abstract][Full Text] [Related]
31. Assessment of a 35% fluorocarbon emulsion.
Gould SA; Sehgal LR; Rosen AL; Langdale LA; Sehgal HL; Krause L; Moss GS
J Trauma; 1983 Aug; 23(8):720-4. PubMed ID: 6887290
[TBL] [Abstract][Full Text] [Related]
32. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
Shrewsbury RP
Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
[TBL] [Abstract][Full Text] [Related]
33. [Effect of fluorocarbon emulsion and dextran on the collateral oxygen-supply to the ischemic myocardium].
Ma XL; Zhao RR; Zang YM; Wang FZ
Sheng Li Xue Bao; 1987 Jun; 39(3):242-7. PubMed ID: 2445037
[No Abstract] [Full Text] [Related]
34. Critical oxygen delivery levels during shock following normoxic and hyperoxic haemodilution with fluorocarbons or dextran.
Faithfull NS; Cain SM
Adv Exp Med Biol; 1987; 215():79-87. PubMed ID: 2445179
[TBL] [Abstract][Full Text] [Related]
35. Myocardial blood flow and O2-supply following dextran-haemodilution and methaemoglobinaemia in the dog.
Biro GP; Beresford-Kroeger D
Cardiovasc Res; 1979 Aug; 13(8):459-68. PubMed ID: 487384
[TBL] [Abstract][Full Text] [Related]
36. Comparative studies with Fluosol, Dextran, their mixture, or autologous blood in experimental hypovolemic shock.
Madjidi A; Beisbarth H; Frey R
Prog Clin Biol Res; 1983; 122():391-7. PubMed ID: 6192451
[TBL] [Abstract][Full Text] [Related]
37. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
Nagasawa S; Handa H; Naruo Y; Oda Y; Yonekawa Y; Takebe Y
Neurol Res; 1981; 3(3):237-50. PubMed ID: 6122175
[TBL] [Abstract][Full Text] [Related]
38. Oxygenated fluosol DA-20% distal infusion during coronary angioplasty protects myocardial function.
Jaffe CC; Wohlgelernter D; Highman HA; Cleman M
Prog Clin Biol Res; 1986; 211():21-7. PubMed ID: 2938192
[No Abstract] [Full Text] [Related]
39. Inadequate subendocardial oxygen delivery during perfluorocarbon perfusion in a canine model of ischemia.
Christensen CW; Reeves WC; Lassar TA; Schmidt DH
Am Heart J; 1988 Jan; 115(1 Pt 1):30-7. PubMed ID: 3336983
[TBL] [Abstract][Full Text] [Related]
40. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
Cleman M; Jaffee CC; Wohlgelernter D
Circulation; 1986 Sep; 74(3):555-62. PubMed ID: 2943533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
